A bicameral coalition of 27 Nevada lawmakers has introduced a resolution urging the U.S. Congress to take action on the therapeutic use of psilocybin, psilocin, DMT, ibogaine, mescaline, and MDMA.

Nevada State Capitol.
Filed yesterday with 27 bicameral sponsors, Senate Joint Resolution 10 was referred to the Committee on Legislative Operations and Elections for further consideration.
SJR10 highlights the growing body of research supporting the use of psychedelics such as psilocybin, MDMA, DMT, ibogaine, and mescaline for treating conditions including post-traumatic stress disorder (PTSD), treatment-resistant depression, and substance use disorders. The resolution points to clinical trials demonstrating significant improvements in mental health outcomes for veterans, first responders, and others suffering from these conditions.
Continue reading